These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

369 related items for PubMed ID: 1578372

  • 1. Pharmacological assessment of the antithrombotic activity of the peptide thrombin inhibitor, D-methyl-phenylalanyl-prolyl-arginal (GYKI-14766), in a canine model of coronary artery thrombosis.
    Jackson CV, Crowe VG, Frank JD, Wilson HC, Coffman WJ, Utterback BG, Jakubowski JA, Smith GF.
    J Pharmacol Exp Ther; 1992 May; 261(2):546-52. PubMed ID: 1578372
    [Abstract] [Full Text] [Related]

  • 2. Comparison of thrombin active site and exosite inhibitors and heparin in experimental models of arterial and venous thrombosis and bleeding.
    Schumacher WA, Steinbacher TE, Heran CL, Seiler SM, Michel IM, Ogletree ML.
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1237-42. PubMed ID: 8263785
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Pharmacological profile of recombinant, human activated protein C (LY203638) in a canine model of coronary artery thrombosis.
    Jackson CV, Bailey BD, Shetler TJ.
    J Pharmacol Exp Ther; 2000 Dec; 295(3):967-71. PubMed ID: 11082430
    [Abstract] [Full Text] [Related]

  • 5. Anti-thrombotic effects of CX-397, a recombinant hirudin analog, in a canine model of coronary artery thrombosis.
    Ohyama T, Hori T, Moriike M, Asano T, Hayashi H, Iwade K, Hosoda S.
    Thromb Haemost; 1998 Feb; 79(2):423-30. PubMed ID: 9493602
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Antithrombotic effect of GYKI-14766 in a canine model of arterial and venous rethrombosis: a comparison with heparin.
    Sudo Y, Lucchesi BR.
    J Cardiovasc Pharmacol; 1996 Apr; 27(4):545-55. PubMed ID: 8847872
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Anticoagulant and antithrombotic action of the synthetic thrombin inhibitor D-phenylalanyl-L-prolyl-L-arginine nitrile.
    Kaiser B, Richter M, Hauptmann J, Markwardt F.
    Pharmazie; 1991 Feb; 46(2):128-31. PubMed ID: 1852761
    [Abstract] [Full Text] [Related]

  • 12. Reversible tripeptide thrombin inhibitors as adjunctive agents to coronary thrombolysis: a comparison with heparin in a canine model of coronary artery thrombosis.
    Jackson CV, Wilson HC, Growe VG, Shuman RT, Gesellchen PD.
    J Cardiovasc Pharmacol; 1993 Apr; 21(4):587-94. PubMed ID: 7681904
    [Abstract] [Full Text] [Related]

  • 13. In vivo anticoagulant and antiplatelet effect of D-Phe-Pro-Arg-H and D-MePhe-Pro-Arg-H.
    Bagdy D, Barabás E, Szabó G, Bajusz S, Széll E.
    Thromb Haemost; 1992 Mar 02; 67(3):357-65. PubMed ID: 1641827
    [Abstract] [Full Text] [Related]

  • 14. Antithrombotic assessment of the effects of combination therapy with the anticoagulants efegatran and heparin and the glycoprotein IIb-IIIa platelet receptor antagonist 7E3 in a canine model of coronary artery thrombosis.
    Shetler TJ, Crowe VG, Bailey BD, Jackson CV.
    Circulation; 1996 Oct 01; 94(7):1719-25. PubMed ID: 8840866
    [Abstract] [Full Text] [Related]

  • 15. Comparison of enoxaparin, hirulog, and heparin as adjunctive antithrombotic therapy during thrombolysis with rtPA in the stenosed canine coronary artery.
    Leadley RJ, Kasiewski CJ, Bostwick JS, Bentley R, McVey MJ, White FJ, Perrone MH, Dunwiddie CT.
    Thromb Haemost; 1997 Oct 01; 78(4):1278-85. PubMed ID: 9364998
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Aspirin does not potentiate effect of suboptimal dose of the thrombin inhibitor inogatran during coronary thrombolysis.
    Chen LY, Nichols WW, Mattsson C, Teger-Nilson AC, Wallin R, Saldeen TG, Mehta JL.
    Cardiovasc Res; 1995 Dec 01; 30(6):866-74. PubMed ID: 8746200
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Antithrombotic and bleeding effects of a new synthetic direct thrombin inhibitor and of standard heparin in the rabbit.
    Cadroy Y, Caranobe C, Bernat A, Maffrand JP, Sié P, Boneu B.
    Thromb Haemost; 1987 Aug 04; 58(2):764-7. PubMed ID: 3672429
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.